Gene · 3598
Papers2,877
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,877
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prediction of anti-TNF therapy failure in ulcerative colitis patients by ensemble machine learning: A prospective study. | Heliyon | 2023 | 37928018 | PubTator, text mining | PubMed |
| Investigating chimeric antigen receptor T cell therapy and the potential for cancer immunotherapy (Review). | Mol Clin Oncol | 2023 | 37920415 | PubTator, text mining | PubMed |
| Siglec-7 glyco-immune binding mAbs or NK cell engager biologics induce potent antitumor immunity against ovarian cancers. | Sci Adv | 2023 | 37910620 | PubTator, text mining | PubMed |
| Engineering CAR-T cells for radiohapten capture in imaging and radioimmunotherapy applications. | Theranostics | 2023 | 37908719 | PubTator, text mining | PubMed |
| A fine mapping of single nucleotide variants and haplotype analysis of IL13 gene in patients with Leishmania guyanensis-cutaneous leishmaniasis and plasma cytokines IL-4, IL-5, and IL-13. | Front Immunol | 2023 | 37908348 | PubTator, text mining | PubMed |
| The tumor micro-environment in pediatric glioma: friend or foe? | Front Immunol | 2023 | 37901250 | PubTator, text mining | PubMed |
| Navigating the Immune Challenge in Glioblastoma: Exploring Immunotherapeutic Avenues for Overcoming Immune Suppression. | Cureus | 2023 | 37900496 | PubTator, text mining | PubMed |
| Exhaled Nitric Oxide and Olfactory Dysfunction in Patients with Asthma: Association with Chronic Rhinosinusitis. | Medicina (Kaunas) | 2023 | 37893494 | PubTator, text mining | PubMed |
| New Therapeutic Perspectives in Prostate Cancer: Patient-Derived Organoids and Patient-Derived Xenograft Models in Precision Medicine. | Biomedicines | 2023 | 37893116 | PubTator, text mining | PubMed |
| Fusobacterium nucleatum and its metabolite hydrogen sulfide alter gut microbiota composition and autophagy process and promote colorectal cancer progression. | Microbiol Spectr | 2023 | 37889013 | PubTator, text mining | PubMed |
| Non-cellular immunotherapies in pediatric central nervous system tumors. | Front Immunol | 2023 | 37885882 | PubTator, text mining | PubMed |
| CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial. | Nat Med | 2023 | 37872225 | PubTator, text mining | PubMed |
| Prognostic risk of immune-associated signature in the microenvironment of brain gliomas. | Front Genet | 2023 | 37867596 | PubTator, text mining | PubMed |
| From signalling pathways to targeted therapies: unravelling glioblastoma's secrets and harnessing two decades of progress. | Signal Transduct Target Ther | 2023 | 37857607 | PubTator, text mining | PubMed |
| Unedited allogeneic iNKT cells show extended persistence in MHC-mismatched canine recipients. | Cell Rep Med | 2023 | 37852175 | PubTator, text mining | PubMed |
| Bringing cell therapy to tumors: considerations for optimal CAR binder design. | Antib Ther | 2023 | 37846297 | PubTator, text mining | PubMed |
| Photodynamic therapy and associated targeting methods for treatment of brain cancer. | Front Pharmacol | 2023 | 37841921 | PubTator, text mining | PubMed |
| Pathomechanism of Pruritus in Psoriasis and Atopic Dermatitis: Novel Approaches, Similarities and Differences. | Int J Mol Sci | 2023 | 37834183 | PubTator, text mining | PubMed |
| Cancer/Testis Antigens as Targets for RNA-Based Anticancer Therapy. | Int J Mol Sci | 2023 | 37834126 | PubTator, text mining | PubMed |
| Customizing cancer treatment at the nanoscale: a focus on anaplastic thyroid cancer therapy. | J Nanobiotechnology | 2023 | 37833748 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3598/papers?page=13